课题基金 / 基金详情

Evaluation and Development of Statistical Methods for Data Harmonization in Molecular Prognostication

Evaluation and Development of Statistical Methods for Data Harmonization in Molecular Prognostication
分子预测中数据协调统计方法的评估和开发
批准号:
10303963
负责人:
Li-Xuan Qin
金额:
$49.63万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-03 至 2024-08-31

项目摘要

项目成果

Li-Xuan Qin的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Survival analysis plays a foundational role in biomedical transcriptomics studies for developing reliable predictors of patient prognosis and treatment response. While survival analysis methods are available to address the issues of high dimensionality and signal sparsity, research is still lacking on the issue of data artifacts associated with disparate experimental handling, which is a pivotal feature of transcriptomics data. Published studies often deal with handling artifacts by borrowing methods that were developed for differential expression analysis, the most popular of which is quantile normalization for microarray data and scaling normalization for sequencing data. Despite the unfounded optimism for such ‘off-label’ uses, we found that normalization may distort a marker’s ordering across samples and subsequently compromise the detection of outcome-associated markers and the accuracy of outcome prediction. Thus, there is a pressing need to re- evaluate existing methods for dealing with these data artifacts and tailor new ones specifically for the derivation of molecular prognosticators so that it can be done accurately and reproducibly. In this proposal, we will first fill the knowledge gap for microRNAs (a class of small RNAs that play an important regulatory role of gene expression in humans) using data that are realistically distributed and robustly benchmarked. We will then develop new methods for managing handling artifacts, leveraging the survival regression framework. We will assess the performance of the new methods in comparison with existing methods using simulation tools and demonstrate their use with an application to ovarian cancer data from The Cancer Genome Atlas. Our project is expected to advance the knowledge needed for optimizing data harmonization in microRNA data and thus accelerating their reproducible translations to clinically useful predictors and for paving the way to press on these issues in RNA data and their translations.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1093/nar/gkac064
发表时间: 2022-06-10
期刊: NUCLEIC ACIDS RESEARCH
影响因子: 14.9
作者: [Dueren, Yannick, Lederer, Johannes, Qin, Li-Xuan]
通讯作者: Qin, Li-Xuan
Making External Validation Valid for Molecular Classifier Development.
使外部验证对分子分类器的开发有效。
DOI: 10.1200/po.21.00103
发表时间: 2021
期刊: JCO precision oncology
影响因子: 4.6
作者: [Wu,Yilin, Huang,Huei-Chung, Qin,Li-Xuan]
通讯作者: Qin,Li-Xuan
DOI: 10.1093/bib/bbab257
发表时间: 2021-11-05
期刊: Briefings in bioinformatics
影响因子: 9.5
作者: [Ni A, Qin LX]
通讯作者: Qin LX
DOI: 10.3389/fgene.2022.838679
发表时间: 2022
期刊: Frontiers in genetics
影响因子: 3.7
作者: []
通讯作者:
CF 2: Biostatistics and Bioinformatics Core
CF 2: Biostatistics and Bioinformatics Core
CF 2: Biostatistics and Bioinformatics Core
CF 2: Biostatistics and Bioinformatics Core
海外基金